Skip to content

Investigate Bladder and Prostate During Emptying With Intermittent Catheter

Explorative Study Investigating the Urinary Bladder and Prostate During Intermittent Catheterization in Healthy Male Adults by Use of MR-scanning.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05560594
Enrollment
12
Registered
2022-09-29
Start date
2022-02-27
Completion date
2022-08-25
Last updated
2022-10-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Function

Brief summary

Explorative study investigating the urinary bladder and prostate during intermittent catheterization in healthy male adults by use of MR-scanning.

Detailed description

12 healthy male adults will be enrolled in the investigation. The study includes one study visit where MR-scans of the bladder and prostate will be performed during normal voiding as baseline measurement followed by measurements during emptying of the bladder with an intermittent catheter (SpeediCath CH12 standard male intermittent catheter).

Interventions

DEVICEColoplast SpeediCath CH12 standard male intermittent catheter

Drainage of the bladder through the urethra when using the SpeediCath standard male intermittent catheter.

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Explore the behavior of the urinary bladder and prostate during emptying the bladder with an intermittent catheter. By use of 3D scanning techniques and dynamic MRI, the objective is to investigate behavior of bladder emptying using an intermittent catheter compared to the voluntary bladder emptying.

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Male * Has given written informed consent * Be at least 18 years of age and have full legal capacity

Exclusion criteria

* Participate in any other clinical investigation * Has symptoms of UTI (Investigator's judgement) * Has known abnormalities and/or diseases in the bladder and/ or the lower urinary tract * Has had previous disease or surgery in lower urinary tract * Has any MR-scanning contraindication - according to MR check list

Design outcomes

Primary

MeasureTime frameDescription
Bladder morphologyWithin 1 year after terminationEvaluate bladder morphology and behavior during emptying of the bladder by performance of 3D and dynamic MRI
Bladder behaviorWithin 1 year after terminationEvaluate bladder behavior when emptying the bladder with an intermittent catheter evaluated by performance of 3D and dynamic MRI

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026